Salmeterol-d3

• CAT Number: S000129
• CAS Number: 497063-94-2
• Molecular Formula: C25H34D3NO4
• Molecular Weight: 418.58
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: 4-[1-deuterio-1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-2-[dideuterio(hydroxy)methyl]phenol
• InChI: InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/i20D2,25D
• InChIKey: GIIZNNXWQWCKIB-LPUTUNIKSA-N
• SMILES: [2H]C([2H])(C1=C(C=CC(=C1)C([2H])(CNCCCCCCOCCCCC2=CC=CC=C2)O)O)O

Salmeterol-d3 (CAS: 497063-94-2), a high-quality pharmaceutical research compound designed for advanced studies in respiratory and pulmonary research. As a deuterated analog of Salmeterol, it offers enhanced stability and improved pharmacokinetic properties. Salmeterol-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for asthma and chronic obstructive pulmonary disease (COPD). Trusted by leading laboratories, Salmeterol-d3 is your go-to solution for cutting-edge respiratory research. Unlock new possibilities in asthma and COPD treatment with Salmeterol-d3, where innovation meets reliability.

Reference

[1]. Panayiotis A Procopiou, et al. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group. Bioorg Med Chem. 2011 Oct 15;19(20):6026-32.
[Content Brief]